A hermetic glass-silicon micropackage with high-density on-chip feedthroughs for sensors and actuators
This paper describes the development of a hermetic micropackage with high-density on-chip feedthroughs for sensor and actuator applications. The packaging technique uses low-temperature (320/spl deg/C) electrostatic bonding of a custom-made glass capsule (Corning 7740, 2/spl times/2/spl times/8 mm/s...
Gespeichert in:
Veröffentlicht in: | Journal of microelectromechanical systems 1996-09, Vol.5 (3), p.166-179 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This paper describes the development of a hermetic micropackage with high-density on-chip feedthroughs for sensor and actuator applications. The packaging technique uses low-temperature (320/spl deg/C) electrostatic bonding of a custom-made glass capsule (Corning 7740, 2/spl times/2/spl times/8 mm/sup 3/) to fine grain polysilicon in order to form a hermetically sealed cavity. High-density on-chip multiple polysilicon feedthroughs (200 per millimeter) are used for connecting external sensors and actuators to the electronic circuitry inside the package. A high degree of planarity over feedthrough areas is obtained by using grid-shaped polysilicon feedthrough lines that are covered with phosphosilicate glass (PSG), which is subsequently reflown at 1100/spl deg/C in steam for 2 h. Saline and DI water soak tests at elevated temperatures (85 and 95/spl deg/C) were performed to determine the reliability of the package. Preliminary results have shown a mean time to failure (MTTF) of 284 days and 118 days at 85 and 95/spl deg/C, respectively, in DI water. An Arrhenius diffusion model for moisture penetration yields an expected lifetime of 116 years at body temperature (37/spl deg/C) for these packages. In vivo tests in guinea pigs and rats for periods ranging from one to two months have shown no sign of infection, inflammation, or tissue abnormality around the implanted package. |
---|---|
ISSN: | 1057-7157 1941-0158 |
DOI: | 10.1109/84.536623 |